MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11. 2019

Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, China.

MicroRNAs (miRNAs) comprise a class of short, non-coding RNAs that directly target 3'UTR of mRNA, causing subsequent degradation or suppression of translation. Here, we verified that miR-199a-5p was significantly down-regulated in mouse NSCLC tissues and human patient samples. To further study the function of miR-199a-5p, lentivirus system was adopted to construct stably over-expressing miR-199a-5p A549, SPC-A1 and H1299 cell lines. Then, miR-199a-5p played a tumor suppression role via directly targeting MAP3K11 gene in non-small cell lung cancer (NSCLC). Elevated miR-199a-5p suppressed cell proliferation and arrested cell cycle in G1 phase. We found that MAP3K11 was negatively correlated with miR-199a-5p in NSCLC patient tissues and mouse xenograft tumors. Our results suggest that miR-199a-5p together with its target gene MAP3K11 is a key factor and constitutes a complicated regulation network in NSCLC.

UI MeSH Term Description Entries

Related Publications

Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
January 2017, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
November 2016, BMC urology,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
December 2013, Molecular and cellular biochemistry,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
January 2016, Oncology reports,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
January 2019, Cellular & molecular biology letters,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
July 2020, Pharmacogenomics,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
March 2022, Journal of thoracic disease,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
July 2019, Oncology reports,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
January 2020, Oncology letters,
Yanli Li, and Detao Wang, and Xue Li, and Yang Shao, and Yanyun He, and Huansha Yu, and Zhongliang Ma
September 2021, Experimental and therapeutic medicine,
Copied contents to your clipboard!